Skip to content

Share

  • Add this article to your LinkedIn page
  • Add this article to your Twitter feed
  • Add this article to your Facebook page
  • Email this article
  • View or print a PDF of this page
  • Share further
  • Add this article to your Pinterest board
  • Add this article to your Google page
  • Share this article on Reddit
  • Share this article on StumbleUpon
  • Bookmark this page
PA IN THE MEDIA

Pioneering stem cell treatment for Crohn’s Disease

PA Consulting’s Paul Stroemer, cell and gene therapy expert, comments on the use of pioneering stem cell treatment for Cohn’s disease in an article in The Independent by Rikki Loftus.

Explaining how the therapy could help, Paul explained that: “In the case of Crohn’s disease, it’s likely that stem cells called Mesenchymal Stem cells (MSCs) will be used, because of their efficacy in treating immune and inflammatory diseases.”

 “These stem cells can turn into many different types of cells, including bone, fat, connective tissue, and blood vessels.

Adding: “After administration, MSCs release growth factors and anti-oxidants, helping to repair cells and tissue in their immediate vicinity. They also release soluble factors that flow through the body affecting other tissues and organs.”

Stem cells also respond to their environments and can interact with white blood cells to help alleviate immune responses during flare ups, potentially reducing the symptoms associated with this.”

They can be administered intravenously or via an injection at site, for example, in the intestines. It is viable that cell therapy of this kind could alleviate the symptoms associated with Crohn’s.”

Read the full and original article here.

This has also been featured in Yahoo! News.

Our new report explores four potential future cell and gene therapy scenarios using our FutureWorlds™ approach

Read more here

Contact the life sciences team